H.M.I. SRL
H.M.I. reported total assets of 265,198 € at the end of the 2025 financial year (annual accounts filed with the NBB on 12 Aug 2026).
The score of H.M.I. shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -6 % Total assets -31 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
H.M.I.'s annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −19,018 € | ||||
| Equity | 254,948 € | ||||
| Cash | 35,211 € | ||||
| EBITDA | −7,258 € | ||||
| Total assets | 265,198 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 12 Aug 2026
- Year ended 31 Dec 2024filed on 09 Oct 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 11 Sep 2023
- Year ended 31 Dec 2021filed on 05 Aug 2022
H.M.I.'s financial analysis
- Solvency96.1%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of H.M.I.
H.M.I.'s publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0870.135.134
- VAT number
- BE0870135134
- Peppol
- Registered · 0208:0870135134 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Nov 2004
- Registered office
- 1081 Koekelberg
- Latest accounts
- 2025 · filed on 12 Aug 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
H.M.I. (SRL) has been based in Koekelberg since 2004, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 19,018 € and equity of 254,948 €; its revenue is not published. Its solvency stands at 96.1%, above the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to H.M.I.
Companies in the same business, of comparable size and area, outside its group.
- AlphaCare Wholesale of pharmaceutical and medical goods Grez-Doiceau · balance sheet 559,557 €
- ASP Belgium Wholesale of pharmaceutical and medical goods Saint-Josse-ten-Noode · balance sheet €2.90m
- Esteve Pharmaceuticals Wholesale of pharmaceutical and medical goods Jette · balance sheet €2.91m
- Enzo Life Sciences Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 142,693 €
- LEXmedical Wholesale of pharmaceutical and medical goods Turnhout · balance sheet 554,561 €
- ELIN Wholesale of pharmaceutical and medical goods Herk-de-Stad · balance sheet 181,098 €
- Pharm'up development Wholesale of pharmaceutical and medical goods Tournai · balance sheet 286,691 €
- Medicatronics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet 236,934 €
Frequently asked questions about H.M.I.
What is the revenue of H.M.I.?
H.M.I. files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of H.M.I.?
In Belgium, the VAT number is the company number prefixed with BE: BE0870135134 for H.M.I., if the company is VAT-registered. Its company number (CBE) is 0870.135.134.
Where is the registered office of H.M.I.?
According to the CBE register, the registered office of H.M.I. is in 1081 Koekelberg.
What is the equity of H.M.I.?
At the close of the 2025 financial year, the equity of H.M.I. amounts to 254,948 €, a solvency of 96.1% of total assets.
Who manages H.M.I.?
The register lists 1 active mandates at H.M.I.. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of H.M.I.
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →